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Introduction
The endocytic pathway contributes to the determination of plasma 
membrane receptor homeostasis by maintaining a balance be-
tween cell surface recycling and intracellular redistribution to 
lysosomes or other organelles. Members of the Rab family of small 
GTPases are essential determinants of traffi  cking outcomes. 
GTP-Rabs coordinate distinct traffi  cking steps by recruiting spe-
cifi  c effector proteins. Rab effectors facilitate an array of processes, 
including vesicle formation, motility, and target organelle tether-
ing and fusion (Stenmark and Olkkonen, 2001; Grosshans et al., 
2006). The GTPase cycle is obligatory for proper Rab function 
because mutants that fail to bind, hydrolyze, or exchange nucleo-
tides generally confer dominant phenotypes (Feng et al., 1995).
Adenoviruses are nonenveloped icosahedral DNA viruses 
that replicate and assemble in the host cell nucleus (Ginsberg, 
1999). The adenovirus genome is divided into early genes involved 
in DNA synthesis, transcription, transport of viral mRNAs, and 
immunomodulation and late genes coding for structural proteins. 
Proteins encoded by the early region 3 (E3) are not required for 
replication but contribute to the viral life cycle by altering the 
traffi  cking and function of cellular proteins involved in adaptive 
immunity and infl  ammatory responses (Lichtenstein et al., 2004b). 
The adenovirus receptor internalization and degradation (RID) 
complex encoded by E3 modulates traffi  cking of several cell sur-
face receptors (Horwitz, 2004). RID is composed of two α sub-
units (formerly E3-13.7 or E3-10.4) and one β subunit (formerly 
E3-14.5). RIDα was initially discovered based on its ability 
to induce down-regulation of the EGF receptor (EGFR) in the 
absence of ligand (Carlin et al., 1989). Subsequent studies dem-
onstrated that the RID complex (RIDα/β) mediates the cell sur-
face removal of TNF receptor 1 (TNFR1; Fessler et al., 2004), 
TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1; 
Tollefson et al., 2001), and Fas (Shisler et al., 1997; Elsing and 
Burgert, 1998; Tollefson et al., 1998). In conjunction with E3-6.7K, 
RIDα/β also reduces the cell surface expression of TRAIL-R2 
(Lichtenstein et al., 2004a). The down-regulation of TNFR1, 
TRAIL-R1, TRAIL-R2, and Fas prevents apoptotic and infl  amma-
tory responses that normally result from exposure to the respective 
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he small guanosine triphosphatase Rab7 regulates 
late endocytic trafﬁ  cking. Rab7-interacting lyso-
somal protein (RILP) and oxysterol-binding protein–
related protein 1L (ORP1L) are guanosine triphosphate 
(GTP)–Rab7 effectors that instigate minus end–directed 
  microtubule transport. We demonstrate that RILP and ORP1L 
both interact with the group C adenovirus protein known 
as receptor internalization and degradation α (RIDα), 
which was previously shown to clear the cell surface of 
several membrane proteins, including the epidermal 
growth factor receptor and Fas (Carlin, C.R., A.E. Tollefson, 
H.A. Brady, B.L. Hoffman, and W.S. Wold. 1989. Cell. 
57:135–144; Shisler, J., C. Yang, B. Walter, C.F. Ware, 
and L.R. Gooding. 1997. J. Virol. 71:8299–8306). 
RIDα localizes to endocytic vesicles but is not homologous 
to Rab7 and is not catalytically active. We show that RIDα 
compensates for reduced Rab7 or dominant-negative (DN) 
Rab7(T22N) expression. In vitro, Cu
2+ binding to RIDα 
residues His75 and His76 facilitates the RILP interaction. 
Site-directed mutagenesis of these His residues results in 
the loss of RIDα–RILP interaction and RIDα activity in cells. 
Additionally, expression of the RILP DN C-terminal region 
hinders RIDα activity during an acute adenovirus infection. 
We conclude that RIDα coordinates recruitment of these 
GTP-Rab7 effectors to compartments that would ordinarily 
be perceived as early endosomes, thereby promoting the 
degradation of selected cargo.
Correspondence to Cathleen Carlin: cathleen.carlin@case.edu
Abbreviations used in this paper: ANOVA, analysis of variance; DN, dominant 
negative; E3, early region 3; EGFR, EGF receptor; Hsp, heat-shock protein; LDL, 
low-density lipoprotein; MTOC, microtubule organizing center; MVB, multivesicular 
body; NMR, nuclear magnetic resonance; ORP, oxysterol-binding protein–related 
protein; RID, receptor internalization and degradation; RILP, Rab7-interacting 
lysosomal protein; TNFR1, TNF receptor 1; TRAIL-R, TNF-related apoptosis-inducing 
ligand receptor.JCB • VOLUME 179 • NUMBER 5 • 2007  966
ligands (Tollefson et al., 1998, 2001; McNees et al., 2002; Fessler 
et al., 2004; Lichtenstein et al., 2004a). EGFR down-regulation 
may reduce cellular release of the neutrophil chemoattractant 
interleukin-8 (Mascia et al., 2003; and unpublished data). The 
combined activity of E3 proteins allows for immune evasion of 
adenovirus-infected cells during acute infections. Induction of 
the E3 promoter during T cell activation in the absence of E1A 
expression suggests that E3 proteins also contribute to the es-
tablishment and maintenance of persistent or latent infections 
(Horvath et al., 1986; Garnett et al., 2002).
Degradative endocytic traffi  cking is a dynamic process 
consisting of early and late stages that generally correlate with 
microtubule-dependent movement toward the interior of the cell. 
Early stages are regulated by Rab5, and the acquisition of Rab7 
is considered to be a critical checkpoint in the determination of 
a degradative versus recycling fate. Late endocytic traffi  cking, 
including ligand-dependent EGFR degradation, is dependent on 
Rab7 (Feng et al., 1995; Vitelli et al., 1997; Ceresa and Bahr, 
2006). Rab7 additionally participates in several related processes, 
including autophagy (Gutierrez et al., 2004), melanosome traf-
fi  cking (Gomez et al., 2001), and phagosome maturation (Roberts 
et al., 2006). To date, the known GTP-Rab7 effector proteins are 
Rab7-interacting lysosomal protein (RILP; Cantalupo et al., 
2001), oxysterol-binding protein–related protein 1L (ORP1L; 
Johansson et al., 2005), Rabring7 (Mizuno et al., 2003), the 
hVPS34/p150 phosphatidylinositol (PtdIns) 3-kinase complex 
(Stein et al., 2003), and the α-proteasome subunit XAPC7 
(Dong et al., 2004). RILP and ORP1L facilitate the recruitment 
of minus end–directed dynein–dynactin motor complexes, re-
sulting in microtubule-dependent retrograde transport toward 
the perinuclear microtubule organizing center (MTOC; Jordens 
et al., 2001; Johansson et al., 2005). A tripartite complex of 
RILP–Rab7–ORP1L has been proposed to be the functional 
unit that both recruits and activates motor complexes (Johansson 
et al., 2007). Additionally, RILP enhances the biogenesis of 
multivesicular body (MVB) transport intermediates, possibly 
through interactions with VPS22 and VPS36 components of the 
ESCRT (endosomal sorting complex required for transport) 
protein-sorting machinery (Progida et al., 2006; Wang and 
Hong, 2006).
Previous studies showed that RIDα postendocytically diverts 
the EGFR to lysosomes via MVBs and that the viral protein is 
localized to early endosomes and MVB-limiting membranes 
(Hoffman et al., 1992a; Hoffman and Carlin, 1994; Crooks 
et al., 2000). However, the molecular basis of RIDα- or RIDα/β-
mediated degradation remains to be elucidated. RIDα lacks in-
trinsic catalytic activity, suggesting it alters traffi  cking primarily 
by modulating host-encoded sorting or traffi  cking machineries. 
In this study, we discovered that RIDα interacts with two of the 
known Rab7 effectors, RILP and ORP1L, and that in vitro inter-
action with RILP is facilitated by Cu
2+ binding to two histidine 
residues in RIDα. Importantly, RIDα enhanced late endocytic 
traffi  cking and compensated for Rab7 gene silencing or dominant-
negative (DN) Rab7 expression. A mutant RIDα that failed 
to associate with RILP was also defective in these GTP-Rab7 
compensatory activities and in mediating the down-regulation 
of EGFR and Fas. Our results suggest that RIDα is a functional 
analogue of GTP-Rab7. This mimicry provides insights into the 
mechanism of enhanced degradation of plasma membrane re-
ceptors by adenovirus and the general cellular requirements for 
late endocytic traffi  cking.
Results
RID𝗂 localization and its cytoplasmic 
tail–binding partners
RIDα is a type II integral membrane protein consisting of a 
short N-terminal cytosolic domain, two transmembrane do-
mains connected by an exocytic loop, and a C-terminal cyto-
solic tail (Fig. 1a; Hoffman et al., 1992b). It is enriched in 
perinuclear vesicles that are dependent on the microtubule net-
work for localization. FLAG-RIDα–containing vesicles are 
dispersed throughout the cytosol upon 30-min treatment with 
the microtubule-disrupting agent nocodazole but not the actin-
disrupting agent cytochalasin D (Fig. 1 b). These data are con-
sistent with previous reports that RIDα is localized to MVBs 
(Crooks et al., 2000) as these and other late endocytic structures 
undergo minus end–directed microtubule transport toward the 
MTOC (Gruenberg, 2001).
We performed a yeast two-hybrid screen of a HeLa cell 
cDNA library using bait encoding the full-length C-terminal tail 
of RIDα. The screen isolated cDNA regions of two GTP-Rab7 
effector proteins, RILP and ORP1. The screen also identifi  ed 
cDNA regions of two heat-shock proteins (Hsps), Hsp60 and 
Hsp90. The shortest cDNA fragment of RILP isolated by the 
yeast two-hybrid screen corresponded to amino acids 261–308 
(Fig. 1 c). We used a series of GST fusion proteins with RIDα 
cytoplasmic tails containing progressive stop codons (Cianciola 
et al., 2007) to verify the interaction and map the RILP-binding 
domain in RIDα (Fig. 1 d). A GST pull-down assay was per-
formed in the presence of 75 μM Cu
2+ with lysates prepared 
from CHO cells transiently overexpressing HA epitope–tagged 
RILP (HA-RILP; Fig. 1 e). This assay verifi  ed the RIDα–RILP 
interaction and demonstrated that the interaction was disrupted 
upon truncation of the RIDα cytoplasmic tail to Ala71. A non-
specifi  c HA epitope–tagged protein did not interact with full-
length GST fusion protein (Fig. 1 f). HA-RILP immobilized on 
an anti-HA affi  nity column also specifi  cally captured purifi  ed 
full-length GST-RIDα cytoplasmic tail fusion protein and not 
purifi  ed GST (Fig. 1 g).
The in vitro binding of RILP with RID𝗂 
is facilitated by Cu
2+
The region of RIDα required for RILP interaction harbors an 
LRHH motif that is also found in the fusogenic peptide B18 
from the sea urchin sperm acrosomal protein bindin (Ulrich 
et al., 1998). The B18 histidine-rich motif is a divalent cation-
coordinating site that regulates fusogenic activity by permitting 
the peptide to adopt different structural conformations in the 
presence of Zn
2+ or Cu
2+ (Sinz et al., 2003). To test whether the 
RIDα sequence interacts with divalent cations, we examined 
the amide-aromatic region of the one-dimensional 
1H nuclear 
magnetic resonance (NMR) spectra of a peptide identical 
to amino acids 69–91 in the absence or presence of divalent ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 967
cations (Fig. 2 a). The proton peaks for this region of the spectra 
have been previously assigned (Vinogradova et al., 1998). 
The addition of a 4:1 molar excess of Zn
2+ or Mg
2+ had no notice-
able effect. However, the addition of Cu
2+ resulted in a pronounced 
broadening of peaks corresponding to the δ
2 and ε
1 side chain 
protons of His75 and His76. This observation strongly suggests 
a specifi  c interaction in vitro between Cu
2+ and these two histi-
dine residues.
Because the RILP- and Cu
2+-interacting domains of RIDα 
overlap, we asked whether Cu
2+ specifi  cally regulates the inter-
action between the full-length RIDα cytoplasmic tail GST fu-
sion protein and HA-RILP. A dose-dependent relationship 
between Cu
2+ concentration and the HA-RILP–GST-RIDα inter-
action was observed (Fig. 2 b). Furthermore, mutation of the 
Cu
2+-binding histidine residues to a dialanine or diserine abol-
ished the interaction between RIDα and HA-RILP (Fig. 2 b). 
These data suggest that the Cu
2+-binding properties of His75 
and His76 are critical for in vitro binding of RIDα and RILP. 
Whether Cu
2+ serves as a bridge between the two proteins or 
facilitates formation of a RIDα conformation required for RILP 
interaction remains to be determined.
Coimmunoprecipitation and colocalization 
of RID𝗂 and RILP
The inability of the GST-RIDα fusion protein harboring a 75AA 
mutation to interact with RILP led us to compare in vivo inter-
actions between RILP and wild-type RIDα or RIDα with a 
 similar  mutation. Coimmunoprecipitation experiments were 
performed in cells stably expressing wild-type or mutant RIDα 
with N-terminal epitope tags and transiently expressing HA-
RILP. Expression of the epitope tag had no effect on RIDα sub-
cellular distribution (unpublished data). Cell lysates were 
immunoprecipitated with an anti-FLAG antibody, and immune 
complexes were probed with antibodies to RIDα or RILP. Intro-
duction of the 75AA mutation had no effect on the formation of 
both molecular weight isoforms of the RIDα protein (Fig. 3 a, 
top). We also found that HA-RILP was present in immune com-
plexes with FLAG-RIDα but not FLAG-RIDα(75AA) (Fig. 3 a, 
bottom). To determine whether these two proteins colocalize in 
cells, stable cell lines transiently expressing GFP-tagged RILP 
(GFP-RILP) were fi  xed and stained for the FLAG epitope and 
examined by confocal microscopy. Consistent with previous 
studies, RILP overexpression induced formation and aggregation 
Figure 1.  RID𝗂 localization and interaction with RILP. (a) Model showing known RIDα membrane topology and C-terminal tail amino acid sequence used 
as bait in a yeast two-hybrid screen. The loop domain in the lumen has a site for signal peptidase cleavage and disulﬁ  de bond formation (Hoffman et al., 
1992b). (b) Stably expressed FLAG-RIDα in CHO cells was stained for the FLAG epitope (red) and with DAPI (blue) after treatment with vehicle or cytoskeleton-
disrupting drugs. Cell peripheries (green) were traced from a phase image using MetaMorph software. (c) Schematic representation of RILP with known 
protein-binding domains. The RIDα-binding domain partially overlaps residues in the second α-helical regions (a1 and a2) previously identiﬁ  ed as the GTP-
Rab7–binding site (Wu et al., 2005). (d) GST fusion proteins with the progressive stop codons introduced at residues highlighted in black in panel a were 
puriﬁ  ed and separated by SDS-PAGE. (e) GST fusion proteins were incubated with lysates from cells overexpressing HA-RILP. Bound proteins were detected 
by a Western blot for the HA epitope tag. (f) GST fusion proteins were incubated with an irrelevant HA-tagged protein and analyzed as in panel e. (g) HA-RILP 
immobilized on an anti-HA afﬁ  nity column was incubated with puriﬁ  ed GST or full-length GST-RIDα cytoplasmic tail. Bound proteins were detected by a 
Western blot for GST. Bars, 10 μm.JCB • VOLUME 179 • NUMBER 5 • 2007  968
of perinuclear vesicles (Jordens et al., 2001; Wang et al., 2004). 
GFP-RILP–positive vesicles were costained with the FLAG anti-
body in cells expressing FLAG-RIDα but not FLAG-RIDα(75AA) 
(Fig. 3 b). Altogether, these studies demonstrate that both in vitro 
and in vivo RIDα–RILP interactions depend on RIDα residues 
His75 and His76. Furthermore, association between FLAG-
RIDα and RILP may also regulate vesicle positioning, as FLAG-
RIDα(75AA) vesicles were relatively dispersed in the cytosol 
compared with vesicles enriched for wild-type RIDα.
To rule out the possibility that the 75AA mutation affects 
RIDα targeting, we verified that FLAG-RIDα and FLAG-
RIDα(75AA) both partially colocalize with two endocytic 
marker proteins, transferrin receptor (Fig. 4 a) and RhoB (Fig. 4 b). 
However, even in a previous study with acutely infected cells that 
reported similar results (Crooks et al., 2000), it has not been pos-
sible to identify markers that precisely overlap RIDα vesicle 
staining. Similar to other intracellular pathogen gene products, 
RIDα appears to occupy an intracellular vesicle that superfi  cially 
resembles an endosome but has modifi  ed the endosome maturation 
process to generate a novel vesicle that benefi  ts adenovirus  survival. 
Additionally, FLAG-RIDα and FLAG-RIDα(75AA) both escape 
the TGN, as neither colocalizes with furin, a TGN marker (Fig. 4 c). 
Thus, 75AA does not appear to adversely affect a nearby clathrin 
AP-1–binding site required for targeting newly synthesized RIDα 
from the TGN to endosomes (Cianciola et al., 2007).
RID𝗂 enhances the size of RILP-labeled 
vesicles
GFP-RILP–labeled vesicles appeared to be larger in cells ex-
pressing RIDα versus RIDα(75AA). To quantitatively address 
this observation, we compared cross-sectional areas of GFP-
RILP–labeled vesicles in parental CHO cells and in CHO cells 
expressing RIDα proteins. The CHO background was chosen 
because of a more uniform cell size and shape within a population. 
Cells were fi  xed and stained with DAPI 12 h after transfection. 
Both phase and confocal serial z-section images were taken for 
25 randomly selected cells, resulting in analysis of >70 vesicles 
for each cell type. The periphery of each cell was traced from the 
z-section phase image demonstrating the greatest cellular area. 
For each GFP-RILP–labeled vesicle, the area was determined 
Figure 2.  Cu
2+ interacts with RID𝗂 and enhances 
RID𝗂–RILP interaction. (a) 1D 
1H NMR spectra 
of the amide/aromatic region of 23 C-terminal 
residues of RIDα illustrating the effects of metal 
ion (Mg
2+, Zn
2+, and Cu
2+) binding. Aromatic 
side chain H
δ2 and H
ε1 resonances of His75 
and His76 (dashed lines) were previously de-
termined (Vinogradova et al., 1998). Selective 
line broadening was observed for histidine side 
chains upon the addition of Cu
2+ but not Zn
+2 or 
Mg
+2. (b) GST pull-down assays were performed 
as shown in Fig. 1 e with fusion proteins encod-
ing the full-length C-terminal tail in the presence 
of indicated cation concentrations. Mutations 
of Cu
2+-binding residues 75HH to 75AA or 
75SS blocked in vitro interactions with RILP.ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 969
from the confocal plane demonstrating the greatest cross-sectional 
area. Representative confocal images merged with the traced cell 
periphery are displayed in Fig. 5 a. The ratio of vesicle to cell 
area was determined, and the mean ratio with the SD for each 
cell type is presented (Fig. 5 b). A mixed effects analysis of vari-
ance (ANOVA) statistical model treatment of the data found the 
difference in vesicle size between CHO-RIDα versus CHO-
75AA or parental CHO cells to be signifi  cant (P < 0.001; Fig. 5 c). 
GFP-RILP appears to retain its ability to recruit the p150
Glued 
subunit of the dynein–dynactin motor complex in the presence 
of RIDα as the enlarged GFP-RILP–labeled vesicles found in 
CHO-RIDα cells colocalize with p150
Glued (Fig. 5 d). Enlargement 
of GFP-RILP–labeled vesicles by RIDα but not RIDα(75AA) 
provides evidence for a functional interaction between RILP and 
RIDα in cells. However, it is not clear whether the increased size 
is caused by enhanced import into GFP-RILP–positive structures 
or decreased export out of these structures.
RID𝗂 compensates for Rab7
A low-density lipoprotein (LDL) degradation assay was used as 
a biological readout for late endocytic traffi  cking. In contrast to 
the LDL receptor that undergoes recycling, LDL is sorted to-
ward lysosomes after ligand–receptor complexes dissociate in 
acidifi  ed endocytic compartments (Jeon and Blacklow, 2005). 
Cells incubated with 
125I-LDL were assayed for the amount of 
radioactivity that was cell surface bound at 0 h, internalized at 
0.5 h, and degraded at 6 h. Stable expression of RIDα or 
RIDα(75AA) in A549 cells did not alter the cell surface binding 
or internalization of LDL (Fig. 6 a), which is consistent with re-
ports that only select cell surface receptors are affected by RIDα 
(Kuivinen et al., 1993). However, A549-RIDα cells demon-
strated a signifi  cant increase (P < 0.005) over parental A549 
and A549-75AA cells in LDL degradation at 6 h (Fig. 6 a), which 
is consistent with the idea that RIDα alters the fate of late 
endocytic lumenal cargo.
It is possible that Rab7 is corecruited to RIDα vesicles 
through interaction with GTP-Rab7 effector proteins. To directly 
address the possibility of Rab7 involvement, we examined late 
endocytic traffi  cking changes initiated by RIDα under condi-
tions of reduced Rab7 expression or during the transient expres-
sion of DN Rab7 constructs. Parental A549 cells, A549-RIDα, 
or A549-75AA were transfected with a Rab7-specifi  c siRNA or 
Rab7 plasmids for 24 h. In all test conditions, the amount the 
125I-LDL surface bound at 0 h and internalized at 0.5 h was es-
sentially identical (unpublished data), which is consistent with 
previous reports that Rab7 does not directly affect LDL receptor 
cell surface expression or internalization (Vitelli et al., 1997). 
Reduced Rab7 expression led to a corresponding decrease in 
LDL degradation in A549 and A549-75AA cells (P < 0.005 for 
both comparisons) but had no effect in A549-RIDα cells (Fig. 6 b). 
RIDα but not RIDα(75AA) rescued the LDL degradation defect 
caused by reduced Rab7 expression,  suggesting that the interaction 
Figure 3.  Colocalization and coimmunopre-
cipitation of RID𝗂 and RILP. (a) Cell lysates from 
GP2-293 cells stably expressing FLAG-RIDα or 
FLAG-RIDα(75AA) and transfected with a plas-
mid encoding HA-RILP were immunoprecipi-
tated with an anti-FLAG antibody and followed 
by a Western blot for FLAG to detect RIDα or 
HA to detect coimmunoprecipitated HA-RILP. 
(b) GP2-293 cells transfected with a plasmid 
encoding GFP-RILP were ﬁ  xed and stained for 
the FLAG epitope tag (red) and with DAPI (blue) 
12 h after transfection. Confocal microscopy 
demonstrates partial merging of GFP-RILP sig-
nals with FLAG-RIDα but not FLAG-RIDα(75AA). 
Bars, 10 μm.JCB • VOLUME 179 • NUMBER 5 • 2007  970
Figure 4.  Localization of RID𝗂 with compart-
ment-speciﬁ  c  markers.  Stable GP2-293 cell 
lines were stained for the FLAG epitope (red), 
with DAPI (blue), and for transferrin receptor 
(a), RhoB (b), and furin (c; green channels). 
Boxed areas are enlarged on the right. Bars, 
10 μm.ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 971
Figure 5.  Enlargement of GFP-RILP–labeled vesicles by RID𝗂. 
(a) CHO, CHO-RIDα, or CHO-75AA cell populations trans-
fected with a plasmid encoding GFP-RILP were ﬁ  xed  and 
stained with DAPI (blue). Images were generated by merging 
of the largest traced cell periphery from a phase image plane 
(red) with a confocal plane representing the largest area for 
an individual GFP-RILP–labeled vesicle (green). Three repre-
sentative images of each cell type are shown. Bar, 10 μm. 
(b) Ratios of vesicle to cell area for every identiﬁ  able vesicle 
(n > 70 for each cell type) were obtained with MetaMorph 
software. Data are presented as mean ratios ± SDs (error 
bars). (c) A mixed effects ANOVA statistical model treatment of 
data found the difference in vesicle size between RIDα versus 
RIDα(75AA) or parental CHO cells to be signiﬁ  cant (P < 0.001). 
(d) GFP-RILP–transfected CHO cells were stained for p150
Glued 
(red) and with DAPI (blue). Boxed areas are enlarged on the 
right. Bars, 15 μM.JCB • VOLUME 179 • NUMBER 5 • 2007  972
Figure 6.  RID𝗂 compensates for Rab7. (a) Cells incubated with 
125I-LDL were assayed for surface-bound (0 h), internalized (0.5 h), 
and degraded LDL in the medium (6 h). Results are presented as per-
centages relative to parental A549 cells. (b, top) 
125I-LDL degradation 
assay was performed in cells transfected with Rab7-speciﬁ  c siRNA 
and incubated for 24 h. Experiments were performed in triplicate on 
two separate occasions. Data (mean ratios ± SDs [error bars]) are 
plotted as percentages of mock-transfected cells and analyzed by t test. 
(bottom) Equal aliquots of total cell protein were Western blotted with 
antibodies against Rab7, actin, and RIDα. (c, top) 
125I-LDL degrada-
tion assay was performed in cells transfected with GFP or GFP-tagged 
Rab7 constructs. (bottom) Transient protein expression was determined 
by Western blotting for GFP.ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 973
between RIDα and RILP is required for RIDα-mediated effects 
on late endocytic traffi  cking.
RIDα also enhanced LDL degradation in the presence of a 
Rab7 DN mutant, Rab7(T22N) (Fig. 6 c). We used constructs ex-
pressing GFP fusion proteins to verify similar transfection effi  -
ciencies in all test conditions (unpublished data). GFP-Rab7(T22N) 
expression resulted in decreased LDL degradation in A549 and 
A549-RIDα(75AA) cells (P < 0.001 for both comparisons) but 
had no effect in A549-RIDα cells. RIDα-mediated enhanced LDL 
degradation circumvented the block induced by GFP-Rab7(T22N), 
which is preferentially bound to GDP (Li et al., 1994), in contrast 
to the nucleotide binding–incapable DN Rab7(N125I) (Bucci 
et al., 1992; Feng et al., 1995), in which there is little effect. Thus, 
RIDα but not RIDα(75AA) promotes a late endocytic traffi  cking 
step that bypasses the requirement for GTP-Rab7.
RID𝗂(75AA) fails to down-regulate cell 
surface EGFR and Fas expression
Because RIDα(75AA) failed to enhance late endocytic traffi  cking, 
we asked whether it would also be defective in the clearance 
of cell surface receptors previously linked to RIDα or RIDα/β 
expression. Our laboratory has reported that RIDα expression is 
necessary and sufficient to induce EGFR down- regulation 
(Hoffman et al., 1990). As measured by fl  ow cytometry, we 
found a reduction in cell surface EGFR expression in A549 cells 
infected with a retrovirus expressing RIDα in contrast to the 
RIDα(75AA) retrovirus, which had no effect (Fig. 7 a). Similar 
results were obtained for Fas, which is down-regulated by the 
RIDα/β complex. A549, A549-RIDα, and A549-75AA cells 
were infected with an adenovirus (dl753) harboring a deletion in 
RIDα but expressing all other adenoviral proteins, notably RIDβ. 
Figure 7.  Down-regulation of cell surface EGFR and Fas. (a) A549 cells infected with retrovirus expressing RIDα or RIDα(75AA) were analyzed for EGFR surface 
expression by ﬂ  ow cytometry 24 h after infection. Data are plotted for uninfected (blue) and infected (red) cells. (b) A549 cells were infected with wild-type adeno-
virus (rec700) or an RIDα deletion mutant (dl753) and were metabolically labeled with [
35S]Cys/Met. Cell lysates were immunoprecipitated with RIDα or RIDβ 
antibodies under nondenaturing conditions and were subjected to SDS-PAGE and autoradiography. (c) A549, A549-RIDα, or A549-RIDα(75AA) cells were in-
fected with dl753 for 18 h, labeled with a FITC-conjugated antibody recognizing the extracellular domain of Fas, and subjected to FACS analysis. Data are plotted 
for uninfected (blue) and infected (red) cells. All experiments were performed on three separate occasions, and a representative experiment is presented.JCB • VOLUME 179 • NUMBER 5 • 2007  974
As previously reported (Tollefson et al., 1990), the expression of 
RIDβ is reduced during dl753 infection compared with the pa-
rental wild-type adenovirus type 5/2/5 hybrid (rec700; Fig. 7 b). 
However, this level of RIDβ expression is suffi  cient to reconsti-
tute cooperative RIDα/RIDβ activity because A549-RIDα in-
fected with the dl753 virus exhibited reduced Fas cell surface 
expression. However, A549-75AA cells did not show reduced 
Fas cell surface expression. These results demonstrate that the 
association of RILP and possibly other unidentifi  ed interactions 
mediated by the histidine residues of RIDα are critical for the 
principle activity of receptor down-regulation ascribed to the 
RID complex.
DN RILP perturbs RID𝗂-mediated EGFR 
down-regulation
Expression of only the C-terminal half of RILP (∆N-RILP en-
coding amino acid residues 199–401) results in a DN phenotype 
(Cantalupo et al., 2001; Jordens et al., 2001), presumably be-
cause the mutant competes with endogenous RILP for GTP-
Rab7 binding and fails to recruit motor complexes (Fig. 1 c). 
Because RIDα also binds the C-terminal region of RILP, we 
asked whether ∆N-RILP perturbs RIDα activity. To address this 
question, we examined the effect of transient ∆N-RILP ex-
pression on the adenovirus-mediated down-regulation of EGFR. 
To ensure measurements of only transfected cells, we used GFP-
tagged ∆N-RILP. A GST pull-down assay revealed that GFP–
∆N-RILP associates with RIDα similarly to GFP-RILP (Fig. 8 a). 
The expression of GFP–∆N-RILP did not appear to hinder 
adenovirus infection compared with control GFP transfection as 
measured by the expression of adenovirus E1A (Fig. 8 b) and 
examination of cellular size and granularity changes by fl  ow 
cytometry (unpublished data). To measure the effect on EGFR sur-
face expression, A549 cells were transiently transfected with 
a plasmid encoding either GFP or GFP–∆N-RILP for 36 h, 
infected with wild-type rec700 adenovirus, and assayed by fl  ow 
cytometry 12 h after infection  (Fig. 8 c). Plots of the transfected 
cells represent cells gated for GFP expression, which represent 
30–40% of the total cell population (unpublished data). Approx-
imately 63% of GFP–∆N-RILP–expressing cells failed to down-
regulate the EGFR upon adenovirus infection (Fig. 8 c). The 
presence of native RILP and other RIDα-interacting proteins 
may account for the lack of complete inhibition of RIDα activity. 
Nonetheless, the DN effect of GFP–∆N-RILP implicates the 
involvement of RILP in adenovirus-mediated EGFR down-
regulation EGFR and suggests that RIDα interacts with RILP 
similarly to GTP-Rab7.
Figure 8.  𝖫N-RILP impairs RID𝗂-mediated EGFR down-regulation. (a) GST fusion proteins were incubated with lysates from cells overexpressing GFP-RILP 
or GFP–∆N-RILP. Bound proteins were detected by a Western blot for GFP. (b) A549 cells were transiently transfected with a plasmid encoding GFP or 
GFP–∆N-RILP and infected with rec700. To ensure that RILP proteins do not interfere with infection, total cell lysates were analyzed for E1A expression by 
Western blotting. (c) A FACS proﬁ  le is presented of the EGFR surface expression of ungated control cells (blue), GFP-transfected, rec700-infected, and GFP-
gated cells (red), and GFP–∆N-RILP–transfected, rec700-infected, and GFP-gated cells (green).ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 975
RID𝗂 additionally interacts with ORP1L
An RILP–Rab7–ORP1L tripartite complex has recently been 
identifi  ed that links GTP-Rab7 to minus end–directed molecular 
motors (Johansson et al., 2007). The authors of this study pro-
vide evidence suggesting this complex forms in a step-wise fash-
ion and that RILP and ORP1L bind simultaneously to GTP-Rab7 
but not to each other. The initial yeast two-hybrid screen for 
RIDα-interactive partners also isolated a cDNA encoding ORP1. 
The shortest ORP1 cDNA fragment corresponded to amino acid 
residues 755–923, a region coded by a shared exon of both ORP1 
isoforms, ORP1S and ORP1L (Fig. 9 a; Jaworski et al., 2001; 
Lehto et al., 2001). We elected to further explore ORP1L based 
on its prevalence over ORP1S in lung tissue, macrophages, and 
monocytes (Johansson et al., 2003) and its reported roles as a 
GTP-Rab7 effector and regulator of MVB morphology (Johansson 
et al., 2005, 2007). Using the same GST-RIDα fusion proteins 
shown in Fig. 1 d, we confi  rmed that ORP1L associated with 
the RIDα cytoplasmic tail downstream of His76 (Fig. 9 b). Inter-
estingly, these results were obtained only when cell lysates 
were immunodepleted for Hsp60 before they were added to 
GST fusion protein affi  nity beads, suggesting that Hsp60 and 
ORP1L compete for binding to the same general region in the 
RIDα cytoplasmic tail (Fig. 9 b). The 75AA and 75SS mutations 
that prevent RILP binding had no effect on the RIDα–ORP1L 
interaction (Fig. 9 c). ORP1L binding also did not appear to be 
dependent on divalent cations (Fig. 9 c). Thus, similar to Rab7, 
RIDα has distinct binding sites for two different effector mole-
cules that may be similarly involved in the step-wise assembly 
of minus end–directed molecular motors.
Discussion
Although RID proteins have been extensively studied for over a 
dozen years, there is still relatively little information regarding 
their molecular basis of action. Data presented in this manuscript 
show for the fi  rst time that the RIDα-interactive host protein 
RILP is required for EGFR down-regulation in adenovirus-
infected cells. Although we have not directly addressed the role of 
RIDβ in these experiments, it seems likely that RILP is also im-
portant for its ability to down-regulate Fas in conjunction with 
RIDα. A deletion mutant in a region of RIDα overlapping the 
known RILP-binding domain has also been shown to prevent 
both EGFR and Fas down-regulation (Zanardi et al., 2003).
There is no appreciable amino acid sequence homology 
between Rab7 and RIDα, suggesting that RIDα developed novel 
modes of interaction with two Rab7 effectors through convergent 
evolution. The RIDα–RILP interaction most likely preserves the 
dynein–dynactin motor complex recruitment and late endosomal/
Figure 9.  RID𝗂 additionally interacts with ORP1L. (a) Schematic representation of ORP1L. The shortest cDNA clone identiﬁ  ed in our screen corresponds 
to amino acids 755–923 in the sterol-binding domain (SD). ORP1L also has a pleckstrin homology domain (PH) and ankyrin repeats (Lehto et al., 2001). 
GTP-Rab7 binding has been mapped to the N terminus (Johansson et al., 2005). (b) ORP1L and Hsp60-binding domains were mapped using the GST 
fusion proteins shown in Fig. 1 d. Total cell lysates were immunodepleted for Hsp60 before addition to GST fusion proteins for ORP1L mapping. (c) ORP1L 
binding to the full-length GST fusion protein was determined in the presence of indicated cation concentrations.JCB • VOLUME 179 • NUMBER 5 • 2007  976
lysosomal clustering properties of RILP, as indicated by the co-
localization of GFP-RILP and p150
Glued in RIDα-expressing cells, 
perinuclear aggregation and enlargement of RILP-positive vesicles 
in the presence of RIDα, and the DN effect of ∆N-RILP. Enlarged 
late endocytic structures are also generated upon the overexpres-
sion of constitutively active Rab7(Q67L) (Bucci et al., 2000), fur-
ther demonstrating GTP-Rab7 mimicry by RIDα. Although it is 
possible that RIDα hinders RILP-mediated budding out of or into 
enlarged endosomes, we consider it more likely that these structures 
refl  ect an increased number of vesicles available for RILP-mediated 
perinuclear convergence as a result of the presence of RIDα.
RIDα residues His75 and His76 interact with Cu
2+ to en-
hance the in vitro binding of RILP. RIDα with a substitution for 
the dihistidine failed to enhance LDL degradation and did not 
mediate cell surface receptor clearance, demonstrating the im-
portance of RILP and other possible interactions with the Cu
2+-
binding region of RIDα. The in vitro use of Cu
2+ may generate 
RIDα conformations capable of binding RILP that were attained 
through different means in vivo. However, Cu
2+ itself may regu-
late the in vivo interaction between RIDα and RILP along with 
resultant effects on traffi  cking, which is similar to the Cu
2+-
dependent interaction between the cytosolic N terminus of the 
late endosome–associated copper transporter ATP7B and the 
dynactin subunit p62 (Lim et al., 2006). Interestingly, another 
E3 protein, 14.7K, binds divalent metals (Zn
2+ and Co
2+), and 
this property is also necessary for recovery of functional 14.7K 
from a bacterial expression system (Kim and Foster, 2002).
The ability of RIDα to enhance LDL degradation in Rab7-
depleted cells or in the presence of DN Rab7(T22N) suggests 
that RIDα facilitates an endocytic traffi  cking route that bypasses 
a step normally regulated by Rab7. Interestingly, RILP over-
expression also overcomes the blockade induced by Rab7(T22N) 
(Cantalupo et al., 2001), suggesting that RIDα mimics RILP 
overexpression by increasing the local recruitment of native 
RILP. RIDα may also regulate other Rab7-dependent processes 
such as phagosome maturation, autophagy, axonal retrograde 
transport, and melanosome transport.
Our yeast two-hybrid screen predicts that ORP1L may also 
be required for functional GTP-Rab7 mimicry by RIDα. Similar 
to RILP, ORP1L overexpression leads to perinuclear clustering 
and enlargement of late endosomes/lysosomes (Johansson et al., 
2003). The overlapping phenotype is not a consequence of 
  redundant effector protein activities but is the result of the simulta-
neous engagement of RILP and ORP1L by GTP-Rab7 leading 
to formation of a tripartite complex (Johansson et al., 2007). 
The coordinated activity of both effectors may be required for 
the formation of a functional minus end–driven dynein–dynactin 
motor complex. RILP interacts with the C-terminal region of 
the dynactin projecting arm, p150
Glued, leading to the recruitment 
of dynein motors to RILP-containing endosomes (Johansson 
et al., 2007). However, this recruitment is insuffi  cient to drive 
minus end transport in the absence of ORP1L. ORP1L may sub-
sequently transfer dynein–dynactin motor complexes to βIII 
spectrin, which interacts with the Arp1 subunit of dynactin 
(De Matteis and Morrow, 2000; Holleran et al., 2001). RIDα 
likely mimics GTP-Rab7 by regulating the assembly of a similar 
RILP–RIDα–ORP1L tripartite complex.
Although Hsps are common false positives, it is conceiv-
able that Hsp60 or Hsp90, which were also identifi  ed by our yeast 
two-hybrid screen, play a physiological role in RIDα function. 
Hsp60 may selectively preclude access of ORP1L to the RIDα 
cytoplasmic tail, similar to its ability to regulate interaction be-
tween the signaling adaptor MyD88 and Toll-like receptor 1 
(Brown et al., 2006). A role for Hsp90 is supported by studies 
with the inhibitor geldanamycin that diverts ErbB2 from a 
recycling to a degradative pathway (Austin et al., 2004) and re-
stores the ligand-mediated degradation of kinase domain mutant 
EGFRs (Yang et al., 2006). In addition, Hsp90 found on the cyto-
solic face of the lysosomal membrane facilitates chaperone-
mediated autophagy (Agarraberes and Dice, 2001).
Potential regulation of RILP and ORP1L recruitment by 
Cu
2+ and Hsp60, respectively, is consistent with a requirement 
for effector protein disengagement for continued vesicle matura-
tion and/or extension of protein half-life. A similar mode of reg-
ulation is achieved by the GTPase cycle of Rab7. It has been 
demonstrated that ORP1L overexpression stabilizes GTP-Rab7 
and leads to impaired TRITC-dextran transport to late endocytic 
compartments (Johansson et al., 2005). This excessive engage-
ment may sequester components or preclude access to compo-
nents necessary for the fi  nal stages of late endosome maturation 
and lysosome fusion. The short cytoplasmic tail of RIDα lacks 
any intrinsic GTPase or catalytic activity and, thus, must rely on 
alternative mechanisms to regulate effector protein engagement.
In addition to these studies, we have previously reported 
that RIDα is necessary and suffi  cient for EGFR down-regulation 
(Hoffman et al., 1990; Cianciola et al., 2007). However, this result 
is controversial, and other investigators contend that RIDβ is also 
necessary based on results obtained by infecting tissue culture 
cells simultaneously with multiple adenovirus mutants (Tollefson 
et al., 1991). Productive infections consist of early, intermediate, 
and late stages characterized by temporal expression of virally 
encoded gene products (Ginsberg, 1999). Viral DNA synthesis 
marks the onset of the intermediate phase when a majority of 
early gene transcripts, including E3, are shut off and the infected 
cell initiates transcription of late viral genes. The E3 transcript is 
alternatively spliced into multiple overlapping mRNAs, termed 
a through i, encoding at least nine proteins (Gooding and Wold, 
1990). RIDα and, to some extent, RIDβ are encoded by transcript f, 
which accounts for  15% of total E3 production during a natural 
infection. Many genetically modifi  ed viruses used to study this 
region involve mutations that up-regulate production of the f tran-
script at the expense of other E3 transcripts. In addition to altering 
E3 transcript ratios, many cell culture experiments are carried with 
DNA synthesis inhibitors to amplify E3 gene expression by block-
ing the early to late transition. Thus, although many E3 functions 
have been identifi  ed in tissue culture, their roles in a natural infec-
tion in which they may be less abundantly expressed and ex-
pressed for relatively brief intervals remain to be determined.
Originally identifi  ed by its ability to down-regulate EGFR 
using a panel of group C adenovirus mutants (Carlin et al., 1989), 
it was subsequently shown that RIDα can form a complex with a 
second E3 protein, RIDβ, in infected cells after a cycloheximide-
enhanced procedure to trigger a synchronous burst of E3 protein 
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enriched in different membrane compartments (Stewart et al., 1995; 
Crooks et al., 2000), which is consistent with the idea that they 
may have independent as well as cooperative functions. We also 
suggest that the seemingly disparate results reported by different 
laboratories are not necessarily in confl  ict (Tollefson et al., 1991). 
RIDβ may alleviate an inhibitory constraint in the context of 
an acute adenovirus infection and/or as a consequence of cyclo-
heximide treatment that is not encountered during our gene 
transfer experiments.
The protein interactions identifi  ed by this study account 
for the diversion of endocytic cargo toward degradation. How-
ever, receptor selection in early endocytic compartments and 
sorting into MVBs remain to be elucidated. Our laboratory has 
demonstrated that RIDα encodes all necessary information to 
select, divert, and sort EGFR. EGFR specifi  city is dependent 
on a shared LLRIL amino acid sequence identity with RIDα 
(Crooks et al., 2000). This sequence motif may usurp a normal 
cellular sorting machinery, as it is also required for ligand-
dependent EGFR degradation (Kil et al., 1999). Other cargoes 
may require adenovirus-encoded accessory molecules to deliver 
specifi  c receptors to dynamic endosomes (Fig. 10). This conjec-
ture is consistent with the observations that RIDβ is capable of 
binding AP-2 (Hilgendorf et al., 2003), that AP-2 is required for 
TNFR1 down-regulation, and that TNFR1 coimmunoprecipi-
tates with the RID complex (Chin and Horwitz, 2005). By en-
gaging both the clathrin adaptor and TNFR1, RIDβ may sort 
TNFR1 to an endosome subsequently diverted to lysosomes by 
an RILP–RIDα–ORP1L complex. Additional selection mea-
sures must exist for the TRAIL receptors and Fas. The ability to 
mix and match different aspects of RID protein function may 
have evolved to allow adenoviruses to fi  ne-tune RID activity in 
different cell types or during acute versus persistent infections.
Figure 10.  Role of RID𝗂 in receptor down-
regulation.  Model depicting EGFR endocytic 
trafﬁ   cking under resting conditions, after lig-
and stimulation, or during RIDα expression. 
Major trafﬁ   cking routes are represented by 
thicker black arrows, and minor trafﬁ  cking 
routes are indicated by thinner gray arrows. 
(a) During resting conditions, a majority of 
EGFRs internalized at a low basal rate recycle 
back to the cell surface. (b) During ligand stim-
ulation, EGFR internalization rates and GTP-
Rab7 recruitment to EGFR-containing vesicles 
are enhanced. GTP-Rab7 binds RILP and 
ORP1L (dashed arrows), which subsequently 
recruit and activate motor proteins that induce 
microtubule-dependent displacement toward the 
MTOC. (c) RIDα associates with EGFR-containing 
vesicles in the early endosomal network under 
resting conditions and recruits GTP-Rab7 effec-
tors RILP and ORP1L, leading to microtubule-
dependent displacement toward the MTOC. 
RIDα also enhances the degradation of LDL 
after its release from internalized LDL receptors 
and acts cooperatively with RIDβ to down-
regulate Fas. Although RIDα and RIDβ are 
enriched in endosomes and plasma mem-
brane, respectively, they can also form physi-
cal complexes that are important for some 
aspects of E3 function.JCB • VOLUME 179 • NUMBER 5 • 2007  978
Materials and methods
Plasmids
Yeast two-hybrid plasmids were gifts from S. Brady-Kalnay (Case Western 
Reserve University, Cleveland, OH). All GFP-Rab7 and GFP-RILP plasmids 
were gifts from C. Bucci (Università di Lecce, Lecce, Italy). ORP1L-express-
ing plasmid was a gift from V. Olkkonen (University of Helsinki, Helsinki, 
Finland). The GFP–∆N-RILP plasmid encoding an N-terminal truncated 
form of RILP (amino acid residues 199–401) was a gift of J. Neefjes (The 
Netherlands Cancer Institute, Amsterdam, Netherlands). Plasmids and 
reagents for pantropic retrovirus generation and the pGFP plasmid were 
obtained from Clontech Laboratories, Inc. pExchange vector was obtained 
from Stratagene.
Yeast two-hybrid methods
The coding sequence for the cytoplasmic C-terminal tail (amino acids 61–91) 
of RIDα from adenovirus serotype 2 was cloned into pEG202 (HIS3) in 
frame with the LexA DNA-binding domain. The RIDα insert was PCR ampli-
ﬁ   ed from a previously generated expression vector using the following 
primers to generate 5′ BamH1 and 3′ NotI restriction sites for directional 
in-frame cloning: forward (5′-C  T  G  T  A  G  T  C  A  T  C  G  C  C  T  G  G  A  T  C  C  A  G  T  T  C  A  T  T  G  -3′) 
and reverse (5′-T  T  C  A  G  G  T  T  C  A  G  C  G  G  C  C  G  C  T  G  T  G  G  G  A  G  G  T  T  T  T  T  T  A  -3′). 
The resulting bait construct was introduced into yeast strain YPH499 
(MATa) harboring the pSH18-34 (URA3) reporter plasmid. The YPH499 
strain transformed with bait and reporter plasmids was mated with strain 
EGY48 (MATα) that was previously transformed with the pJG4-5 (TRP1) 
HeLa cell cDNA library controlled by the GAL promoter. The EGY48 strain 
also contains a chromosomal copy of the LEU2 gene, in which the acti-
vating sequences of the LEU2 gene are replaced with LexA operator 
  sequences. Potential interactions were detected by growing the mated yeast 
strain on minimal His-Trp-Ura-Leu dropout plates containing 2% galactose 
and 1% rafﬁ  nose. Colonies were selected for galactose-dependent growth 
on His-Trp-Ura-Leu dropout medium in combination with high levels of 
β-galactosidase activity. Positive interactions were determined by combined 
library and bait plasmid expression–dependent growth. Colonies were fur-
ther selected on the basis of high levels of transcriptional activation of the 
β-galactosidase reporter plasmid as measured by the intensity of blue staining. 
Lastly, isolated library plasmids were assayed for the inability to interact 
with nonspeciﬁ  c test bait. Protein interaction partners were identiﬁ  ed by 
BLASTn search using library plasmid DNA sequences generated from the 
primer 5′-T  A  C  C  G  T  T  A  A  G  C  G  C  C  T  G  A  A  A  A  -3′ that were designed to initiate 
sequencing  100 bp upstream of the fusion site.
Yeast two-hybrid results
The following proteins were identiﬁ  ed in the yeast two-hybrid screen: RILP 
(amino acids 261–308), ORP1 (amino acids 755–923), Hsp60 (amino 
acids 434–573), and Hsp90 (amino acids 1–180).
GST fusion protein generation and puriﬁ  cation
Methods for cloning and mutagenesis of GST fusion proteins have previ-
ously been described (Cianciola et al., 2007). BL-21 cells harboring GST 
fusion protein expression plasmids were lysed with 0.1 mg/ml lysozyme, 
and nucleic acids were digested with 40 μg/ml DNase and 20 μg/ml 
RNase. Sarcosyl and Triton X-100 were added to a ﬁ  nal concentration of 
1.5% and 3.0%, respectively, and cell debris was cleared by centrifuga-
tion at 14,000 g. Glutathione–Sepharose beads (GE Healthcare) were 
added to cleared lysates and incubated overnight at 4°C. Beads were 
washed nine times with 50 mM Tris, pH 7.4, 10 mM MgCl2, 1% Triton 
X-100, and diminishing concentrations (1.0 M to 150 mM) of NaCl. Fusion 
proteins were eluted from beads and dialyzed with 0.05 M Tris, pH 8.0, 
according to standard protocols.
GST pull-down assay
10
6 CHO cells were plated on 100-mm dishes and transfected with 10 μg 
plasmid DNA encoding either HA-RILP or ORP1L using 30 μl CHO-TransIT 
(MirusBio) reagent according to the manufacturer’s instructions. 24 h later, 
cells were washed with PBS and harvested with lysis buffer (20 mM Hepes, 
pH 7.6, 100 mM NaCl, 1% NP-40, 0.2 mM PMSF, and 1 μM leupeptin). 
Lysates were supplemented with the appropriate cation when noted. For 
ORP1L pull-downs, the cell lysate was additionally incubated with 10 μg 
anti-Hsp60 antibody (Santa Cruz Biotechnology, Inc.) attached to protein A–
Sepharose (Sigma-Aldrich) for 2 h before its addition to glutathione 
beads that were previously loaded with the appropriate GST fusion pro-
tein. Fusion proteins were incubated with cell lysates at 4°C overnight. 
Beads were washed four times with lysis buffer, and bound proteins were 
solubilized with 2× laemmli buffer (National Diagnostics). Proteins were 
resolved by SDS-PAGE and Western blotting using anti-HA (Sigma-Aldrich) 
or anti-ORP1 (Imgenex).
Generation of stable cell lines
Previously cloned Ad2 full-length RIDα with and without an N-terminal 
FLAG tag was ampliﬁ  ed by PCR using Taq polymerase and primers with 
5′ NotI and 3′ BsiWI restriction site overhangs and was cloned into the 
TA cloning vector pCR2.1 (Invitrogen). The following primers were used 
to generate the insert: forward with FLAG (5′-C  T  C  G  A  A  A  T  T  A  A  C  C  C  T  C  A  C  T-
A  A  A  G  G  G  A  A  C  A  A  A  A  G  C  -3′), forward without FLAG (5′-T  T  A  C      A  A  G  C  G  G-
C  C  G  C  A  C  G  A  T  A  A  G  A  T  C  A  T  G  A  T  T  C  C  T  -3′), and reverse (5′-T  C  G  A  G  G  T  C  G  A-
C  G  G  T  A  T  C  G  T  A  C  G  G  C  T  T  G  A  T  A  T  C  T  G  A  T  -3′). Nucleic acids coding for the 
dihistidines at positions 75 and 76 were mutagenized to encode dialanines 
using the Quick Change Mutagenesis kit (Invitrogen) using the primers 
(HH75AA) forward (5′-C  G  T  A  C  C  T  C  A  G  G  G  C  C  G  C  T  C  C  G  C  A  A  T  A  C  A  G  A  G  A-
C  A  G  -3′) and (HH75AA) reverse (5′-C  T  G  T  C  T  C  T  G  T  A  T  T  G  C  G  G  A  G  C  G  G  C  C-
C  T  G  A  G  G  T  A  C  G  -3′). Wild-type and mutant RIDα constructs were then sub-
cloned into the pQCXIN bicistronic retroviral packaging vector using the 
NotI and BsiWI restriction sites upstream of the IRES element and neomycin 
resistance gene. The plasmids were introduced into the GP2-293 cells with 
293 Trans-IT (MirusBio) transfection reagent, and pantropic retroviral parti-
cles were generated upon subsequent transfection of the pVSV-G plasmid. 
The retroviruses were used to infect CHO or A549 cells, and populations 
of cells with stable wild-type or mutant RIDα expression were generated by 
selection in 200 μg/ml G418 (EMD)-containing medium.
Coimmunoprecipitation
Cells were lysed in a 10-mM phosphate solution, pH 7.8, supplemented 
with 150 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 1 mM PMSF, and 
1 μg/ml leupeptin for 15 min on ice. Clariﬁ  ed supernatants were incubated 
with anti–FLAG-M2 agarose (Sigma-Aldrich), anti-RIDα, or anti-RIDβ over-
night at 4°C. Beads were washed eight times with a 50-mM phosphate 
solution, pH 7.8, supplemented with 150 NaCl and 0.05% Triton X-100. 
Immune complexes were resolved by SDS-PAGE and transferred to nitrocel-
lulose for immunoblotting or autoradiography using standard methods.
NMR measurements
A peptide corresponding to RIDα amino acids 69–91 was purchased from 
EZ Biolab. NMR spectra were recorded at 25°C on a spectrometer (Avance; 
Bruker-Biospin) operating at a 
1H resonance frequency of 600 MHz and 
equipped with a triple resonance cryoprobe with z-axis pulsed ﬁ  eld gradients. 
Spectra were recorded with 4,096 complex data points and a sweep width 
of 8,012.8 Hz. Solvent suppression was achieved with presaturation during 
the 3-s recycle delay. All free induction decays were apodized with a cosine 
window function and 0.5 Hz of exponential line broadening and were 
zero ﬁ  lled to 65,536 data points before Fourier transformation.
Confocal laser-scanning microscopy
Cells grown on coverslips coated with poly-L-lysine were transfected with a 
plasmid encoding GFP-RILP using the CHO Trans-IT or 293 Trans-IT (Mirus-
Bio) transfection reagents. All CHO cell lines had similar levels of transfec-
tion efﬁ   ciency and gene expression as measured by control GFP and 
luciferase test transfections. Transfected cells were incubated for 12 h at 
37°C. As indicated, cells were treated for 30 min with 100 μM nocodazole 
(Sigma-Aldrich), 40 μM cytochalasin D (Sigma-Aldrich), or DMSO vehicle. 
For localization experiments, cells were ﬁ  xed with 3% PFA, perforated with 
0.5% β-escin, stained with anti-FLAG antibody (Sigma-Aldrich), antitrans-
ferrin (Abcam), anti-RhoB (Santa Cruz Biotechnology, Inc.), anti-furin (R&D 
Systems), or anti-p150
Glued (BD Biosciences), and followed by a Rhoda-
mine red X–conjugated secondary antibody (Jackson Immunochemicals) 
and DAPI. For vesicle size measurements, cells were ﬁ  xed with 3% PFA and 
stained with DAPI. Cells were examined with a confocal microscope (TCS 
SP2 with AOBS; Leica) using the 405-nm wavelength line of a UV laser 
and the 488/568-nm lines of an argon-krypton laser. Image resolution 
using a 100× 1.4 NA oil immersion lens (Leica) and LCS software (Leica) 
was 512 × 512 pixels. Images were analyzed with MetaMorph software 
(MDS Analytical Technologies).
Statistical analysis
A mixed effects ANOVA model, with cell type being treated as a ﬁ  xed ef-
fect and the individual cells considered random effects nested within cell 
type, was selected to model the data. Two responses were considered: 
(1) ratio of vesicle size to cell area and (2) ratio of vesicle perimeter to cell 
  perimeter. Preliminary investigation of these responses indicated that a log ADENOVIRUS RIDα MIMICS GTP-RAB7 • SHAH ET AL. 979
transformation would be necessary to satisfy the normal error assumption 
of the ANOVA model. This model can be described as log(yijk) = μ + αi + 
bj(i) + εijk, where yijk denotes the kth response of the ith cell type and the jth 
cell within the ith cell type. The overall mean effect is given by μ; α refers 
to the ﬁ  xed cell type effect, and b is the random cell within the cell type 
  effect. The normal residual error of the model is denoted by ε.
Rab7 depletion
A549 cell transfections were performed using the Nucleofecter I system 
(Amaxa Biosystems) according to the protocol for solution T. Approximately 
10
6 A549, A549-RIDα, or A549-75AA cells were transfected with 10 or 
20 pg Rab7 siRNA speciﬁ  cally targeting human Rab7 (Dharmacon), or 
2 μg of plasmid DNA encoding GFP, GFP-Rab7(Q67L), GFP-Rab7(N125I), 
GFP-Rab7(T22N), or GFP-RILP. Protein expression was determined with 
an anti-Rab7 antibody or anti-GFP antibody (Sigma-Aldrich) followed by 
HRP-conjugated secondary antibody and ECL substrate (GE Healthcare). 
We used constructs expressing GFP fusion proteins to verify similar trans-
fection efﬁ  ciencies in all test conditions.
LDL degradation
LDL was labeled with 
125I using a chloramine-T–based labeling procedure. 
In brief, 500 μg LDL at 5 mg/ml (Athens Research and Technology) was 
combined with 2 mCi of free 
125I in 500 μl of 250-μM phosphate buffer, 
pH 7.4, and incubated with 150 μl of 5-mg/ml chloramine-T in phos-
phate buffer for 30 s. The reaction was stopped with N2S2O5 and NaI. 
125I-labeled LDL was separated from free 
125I by running the reaction through 
a Sephadex G-25 desalting column (Thermo Fisher Scientiﬁ  c). Transfected 
cells were split into a six-well plate and incubated for 24 h in media supple-
mented with LDL-deﬁ  cient serum (Sigma-Aldrich). The degradation assay 
was performed as previously described (Goldstein et al., 1983; Cantalupo 
et al., 2001). In brief, cells were incubated with 50 μg/ml 
125I-LDL for 6 h. 
Cell culture supernatant was collected, and the amount of degraded 
125I-LDL 
was determined as described previously (Brown and Goldstein, 1975). 
Duplicate transfections were analyzed for total 
125I-LDL that was surface 
bound 30 min after the addition of 
125I-LDL on ice, and total 
125I-LDL internal-
ized at 1 h. All measurements are presented as a percentage of mock or 
control pGFP-transfected A549 cells. Experiments were performed in tripli-
cate on two separate occasions and are presented as a mean of all experi-
ments with SDs. Analysis of signiﬁ  cance was performed with a t test.
Flow cytometry
Cells were infected at 200 MOI with adenovirus dl753 (Carlin et al., 
1989), rec700, or pantropic retroviruses expressing RIDα (retroN RIDα) or 
RIDα(75AA) (retroN RIDα(75AA)). Cells were harvested at 20 h after infec-
tion using 0.025% EDTA in PBS. Cells were washed with PBS supplemented 
with 0.5% FBS (PBS-FACS) and incubated with 1% normal goat serum for 
30 min to block nonspeciﬁ  c binding of the secondary antibody. All subse-
quent washes were performed with PBS-FACS. EGFR cell surface expression 
was determined using 1 μg/ml anti-EGFR monoclonal antibody EGFR1 fol-
lowed by 1 μg/ml FITC-conjugated goat anti– mouse antibody (Jackson 
ImmunoResearch Laboratories). Fas cell surface expression was determined 
using a FITC-conjugated anti-Fas antibody (Novus Biologicals). Cell-associated 
FITC activity was determined using a ﬂ  ow cytometer (LSR I; BD Biosciences) 
and CellQuest software (BD Biosciences).
Metabolic labeling
Cells were rinsed twice and preincubated in methionine and cysteine-free 
medium for 1 h followed by a 3-h incubation with 1,175 Ci/mmol 
[
35S]Express Protein Labeling Mix (New England Nuclear Research Prod-
ucts) diluted in the amino acid–deﬁ  cient medium supplemented with 10% 
dialyzed FBS and 0.2% BSA. Radiolabeled cells were rinsed three times 
with PBS and lysed with 1% (wt/vol) Triton X-100 in 0.1 M Tris, pH 7.4, 
supplemented with 2 mM EDTA, 1 mM EGTA, 0.2 mM PMSF, and 1 μM 
leupeptin for immunoprecipitation with previously described rabbit peptide 
antibodies to individual RID complex components (Tollefson et al., 1990; 
Hoffman et al., 1992b).
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